In conclusion, a novel peptide LC4 targeting CTLA-4 was identified by phage display bio-panning, which has specific affinity with CTLA-4 and blocks the interaction between CTLA-4 and its CD80 ligand, which inhibits tumour growth. Here, CTLA4 is linked to neoplasm.